Market Overview

Center for Vein Restoration Providing Essential Care During COVID-19 Pandemic

Share:

Clinical leaders, with 90 locations nationwide, committed to providing important vascular services to relieve hospital burdens amid COVID-19 concerns; suspend elective cosmetic treatments

GREENBELT, Md. (PRWEB) March 23, 2020

Center for Vein Restoration (CVR), the national leader in treating venous disorders, is affirming its commitment to the healthcare community during the COVID-19 pandemic. CVR locations nationwide will continue delivering essential medical services such as STAT DVT (Deep Vein Thrombosis) Rule-Outs and wound care for venous ulcers, among other critical vascular treatments and diagnoses, keeping patients out of high-exposure risk hospitals and emergency rooms. To ensure accessibility, Center for Vein Restoration is also waiving patient co-pays through April 30 and are seeing all patients irrespective of insurance status.

"We are here for the community," said Sanjiv Lakhanpal, MD, FACS, Cardiovascular surgeon, as well as President and CEO of CVR. "We are rallying our teams in providing essential care that can help those on the front lines in real time. All 90 of our centers will take vascular emergencies and triage them in an effort to get patients safe treatments outside of a hospital setting."

At this time, CVR is suspending all elective cosmetic sclerotherapy treatments through April 30.

"It's our duty to be efficient and part of the solution. We are keeping active dialogue with local, county, and state health boards – offering our support and expertise," said Dr. Khanh Nguyen, Chief Medical Officer. "Primary care physicians should know CVR is prioritizing the care of their patients to ensure safety and efficiency at all our centers," he ended.

CVR has convened a COVID-19 Response Team charged with navigating these unprecedented times.

"This pandemic is all encompassing, no question," said VP of Human Resources, Wendy Walker. "While it's critical we serve our mission and be part of the healthcare solution, we have an enormous responsibility to our employees to make sure they can provide this care in the safest way possible. We're taking every precaution." CVR has over 500 employees throughout 18 states and Washington, DC.

More information on Center for Vein Restoration's COVID-19 response is available at: http://www.centerforvein.com/coronavirus

ABOUT VENOUS INSUFFICIENCY

Venous insufficiency, the cause of significant suffering due to the sequelae of venous hypertension, most commonly arises as achy, tired and heavy legs. It may or may not be associated with varicose veins, spider veins or skin changes including venous ulcerations and indiscriminately affects between 30–40 million Americans. Numerous factors including age, weight, prolonged sitting or standing, genetics or a history of DVT (blood clots) can increase the risk of developing this common and often underdiagnosed disorder. Treatment options have evolved to an array of minimally invasive procedures in an office setting.

ABOUT CENTER FOR VEIN RESTORATION

Center for Vein Restoration (CVR) is the largest physician-led practice treating vein disease in the country. Having performed its first procedure in 2007 under President and CEO Dr. Sanjiv Lakhanpal, Center for Vein Restoration has since become nationally recognized as the clinical leader in treating chronic venous insufficiency. With 90 centers and growing, CVR has over 500 employees and conducts over 200,000 patient interactions annually. To learn more about CVR and its mission, visit http://www.centerforvein.com or by phone at 1-800-FIX-LEGS.

For the original version on PRWeb visit: https://www.prweb.com/releases/center_for_vein_restoration_providing_essential_care_during_covid_19_pandemic/prweb16998315.htm

View Comments and Join the Discussion!
 
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com